PMID: 639834Mar 17, 1978Paper

Effect of metoprolol on blood glycerol, free fatty acids, triglycerides and glucose in relation to plasma catecholamines in hypertensive patients at rest and following submaximal work

European Journal of Clinical Pharmacology
A NilssonB Hökfelt

Abstract

Studies were performed in nine male patients with moderate hypertension. Treatment with metoprolol, 50--150 mg three times daily for 4--17 weeks, had no effect on the plasma level of glycerol, free fatty acids, triglycerides or glucose under basal conditions, neither in the supine nor in the upright position. Submaximal work, performed postprandially, increased plasma glycerol before medication but not during metoprolol, in spite of a marked increase in plasma noradrenaline. The work load employed caused no change in free fatty acids, triglycerides or glucose, neither before medication nor during metoprolol.

References

Jan 1, 1976·Drugs·H J Waal-Manning
Jul 31, 1976·British Medical Journal·S P Deacon, D Barnett
Jul 9, 1977·British Medical Journal·A NilssonB Hökfelt
Apr 16, 1977·British Medical Journal·C L van HerwaardenA van t'Laar
Jun 1, 1976·Journal of Applied Physiology·H GalboJ Hilsted
Jul 1, 1976·Clinics in Endocrinology and Metabolism·P Björntorp
Oct 1, 1967·The Journal of Clinical Endocrinology and Metabolism·E J Pinter, C J Pattee
May 1, 1959·Clinica Chimica Acta; International Journal of Clinical Chemistry·V MARKS
Apr 1, 1960·The Journal of Clinical Investigation·J T HAMLINR G HOSKINS

❮ Previous
Next ❯

Citations

Jan 1, 1983·European Journal of Clinical Pharmacology·S HögstedtA Rane
Jan 1, 1980·Pharmacology & Therapeutics·B N Prichard, C W Owens
Sep 27, 1979·The New England Journal of Medicine·J Koch-Weser
Jun 16, 1984·British Medical Journal·N R PedenB T Martin
Oct 1, 1979·Postgraduate Medical Journal·I W BeinartC W Havard
May 15, 1987·The American Journal of Cardiology·B N Prichard
Sep 15, 1991·The American Journal of Cardiology·D Deleu, K Bohle
May 10, 2005·Respiratory Physiology & Neurobiology·J L MacarlupúF Favret
Nov 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S JohanssonC Wilhelmsson
Jun 1, 1980·British Journal of Clinical Pharmacology·H J Waal-Manning, P Bolli
Jan 1, 1982·Acta Medica Scandinavica·H J JürgensenO Faergeman
Jan 1, 1982·British Journal of Clinical Pharmacology·B N Prichard
Jan 15, 1981·Klinische Wochenschrift·F W Lohmann
Mar 1, 1984·Klinische Wochenschrift·W KroneH Greten

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.